BOSTON, March 25, 2026 (GLOBE NEWSWIRE)-- Avalyn Pharma Inc., (“Avalyn” or the “Company”), a clinical-stage biopharmaceutical company pioneering inhaled therapies to transform the treatment paradigm ...
Findings provide early evidence supporting potential disease-modifying activity of AP01 (inhaled pirfenidone) in patients with IPF BOSTON, March 25, 2026 (GLOBE NEWSWIRE)-- Avalyn Pharma Inc., ...
Young, T. , Guymon, J. , Pankow, M. and Ngaile, G. (2026) A Material Removal Prediction Framework for Ball EEM Polishing in ...
All procedures were in accordance with the US National Institutes of Health (NIH) guidelines for the care and use of laboratory animals and were approved by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results